Tuesday, October 13, 2026

CBOE Went Up By Over 26% In The Last 21 Sessions

ViaNews Editorial Team

September 27, 2023

CBOE Went Up By Over 26% In The Last 21 Sessions

(VIANEWS) - CBOE (VIX) has been up by 26.09% for the last 21 sessions. At 17:09 EST on Wednesday, 27 September, CBOE (VIX) is $18.22.

Regarding CBOE's yearly highs and lows, it's 17.32% up from its 52-week low and 48.02% down from its 52-week high.

Volatility

CBOE's last week, last month's, and last quarter's current intraday variation average was 6.04%, 1.20%, and 4.14%, respectively.

CBOE's highest amplitude of average volatility was 7.92% (last week), 4.62% (last month), and 4.14% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CBOE's is considered to be oversold (<=20).

News about

  • According to DailyForex on Monday, 25 September, "The S&P 500 must navigate a multitude of global challenges, encompassing questions about global growth and inflation.", "In conclusion, the S&P 500 has demonstrated some stabilization at a critical support level, but a range of challenges looms on the horizon. "
  • According to MarketWatch on Monday, 25 September, "See also: was up 0.8% premarket and has gained 54% to date in 2023, while the S&P 500 SPX has risen 12.5%."
  • According to Zacks on Monday, 25 September, "The S&P 500 and the Nasdaq, in particular, registered their biggest weekly percentage drop since March, per Dow Jones Market Data.", "The broader S&P 500 and the tech-laden Nasdaq notched their third successive weekly decline, while the 30-stock Dow ended in the red for the fourth consecutive trading day on Sep 22, witnessing its longest daily declining streak since June."
  • According to MarketWatch on Monday, 25 September, "The stock has gained 258% in the year to date, while the S&P 500 has gained 12.5%. "
  • According to MarketWatch on Monday, 25 September, "See also: was up 0.8% premarket and has gained 54% to date in 2023, while the S&P 500 SPX has risen 12.5%."

More news about CBOE (VIX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com